Mike Cusnir MD
Complementary and Integrative
Medical Director Mount Sinai Comprehensive Cancer Center Division Chief Hematology and Oncology Mount Sinai Comprehensive Cancer Center Miami Beach Florida
Dr. Cusnir is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Arizona College of Medicine-TucsonFellowship, Integrative Medicine, 2010 - 2012
- University of MarylandFellowship, Hematology and Medical Oncology, 2000 - 2003
- Maimonides Medical CenterResidency, Internal Medicine, 1997 - 2000
- Pontifical Xavierian UniversityClass of 1994
Certifications & Licensure
- FL State Medical License 2003 - 2027
- MD State Medical License 2001 - 2004
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Top Doctors:South Florida Castle Connolly, 2012
- Top MD Consumers Checkbook
Clinical Trials
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
- Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC Start of enrollment: 2019 Sep 20
- A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer Start of enrollment: 2018 Jun 19
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsManagement of Locally Advanced Rectal Cancer: ASCO Guideline.Aaron J Scott, Erin B Kennedy, Jordan Berlin, Gina Brown, Myriam Chalabi
Journal of Clinical Oncology. 2024-10-01 - Improving survival in metastatic colorectal cancer through optimized patient selection.Tanios S Bekaii-Saab, Afsaneh Barzi, Mike Cusnir
Clinical Advances in Hematology & Oncology. 2024-06-01 - Sequencing third-line therapies for metastatic colorectal cancer: a guide for determining which therapy to use first.Mike Cusnir
Clinical Advances in Hematology & Oncology. 2024-06-01
Press Mentions
- Dr. Cusnir on the Role of Ramucirumab in Gastric CancerFebruary 5th, 2020
- Novel Agents and Strategies Propelling Progress in Gastric CancerJanuary 3rd, 2020
- Immunotherapy Is Giving Some Cancer Patients a New Life When They Had All but Given up | Miami HeraldMay 25th, 2018
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: